Considering that GnRH therapy can reduce ER and PR expression in uterine leiomyomas [13], the ER and PR positivity of the uterine IMT in this case might have been reduced by GnRH therapy. The gene discussed is GNRH1; the disease is uterine corpus leiomyoma.